D.A. Davidson & Co’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-4,775
Closed -$153K 1711
2017
Q2
$153K Hold
4,775
﹤0.01% 1075
2017
Q1
$165K Sell
4,775
-93
-2% -$3.32K ﹤0.01% 1024
2016
Q4
$171K Buy
4,868
+93
+2% +$3.14K ﹤0.01% 1073
2016
Q3
$165K Buy
+4,775
New +$167K ﹤0.01% 1022
2015
Q2
Sell
-2,080
Closed -$70K 2268
2015
Q1
$70K Hold
2,080
﹤0.01% 1288
2014
Q4
$73K Sell
2,080
-70
-3% -$2.36K ﹤0.01% 1282
2014
Q3
$70K Hold
2,150
﹤0.01% 1271
2014
Q2
$73K Hold
2,150
﹤0.01% 1277
2014
Q1
$75K Buy
+2,150
New +$75.9K ﹤0.01% 1260

Other funds holding ACH

D.A. Davidson & Co's ACH Position: Q3 2017 in Review

D.A. Davidson & Co sold out of Accendra Health (ACH) in Q3 2017, closing a stake of 4,775 shares — an estimated $153K sold.

D.A. Davidson & Co first reported a position in ACH in Q1 2014 and held it in 9 quarters. The position peaked at $171K in Q4 2016. 260 funds tracked by Wall St. Rank hold ACH as of Q3 2017.

  • D.A. Davidson & Co reported no remaining Accendra Health position as of Q3 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 4,775 Accendra Health shares in Q3 2017, an estimated $153K.
  • D.A. Davidson & Co first reported a position in Accendra Health in Q1 2014 and held it in 9 quarters.
  • D.A. Davidson & Co's Accendra Health position peaked at $171K in Q4 2016.
  • 260 funds tracked by Wall St. Rank held Accendra Health as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.